ASH Letter re FDA Draft on Pediatric Drug Development
Citations
American Society of Hematology. (1).
ASH Letter re FDA Draft on Pediatric Drug Development.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development.
American Society of Hematology.
"ASH Letter re FDA Draft on Pediatric Drug Development." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development
(label-accessed May 13, 2024).
"American Society of Hematology."
ASH Letter re FDA Draft on Pediatric Drug Development, 13 May. 2024 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-letter-re-fda-draft-on-pediatric-drug-development.
